Using machine learning to identify diabetes patients with canagliflozin prescriptions at high‐risk of lower extremity amputation using real‐world data
Authors:
- 19 February 2021
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 30 (5) , 644-651
Abstract
Aims: Canagliflozin, a sodium‐glucose cotransporter 2 inhibitor indicated for lowering glucose, has been increasingly used in diabetes patients because of its beneficial effects on cardiovascular and renal outcomes. However, clinical trials have documented an increased risk of lower extremity amputations (LEA) associated with canagliflozin. We applied machine learning methods to predict LEA among diabetes patients treated with canagliflozin.Methods: Using claims data from a 5% random sample of Medicare beneficiaries, we identified 13 904 diabetes individuals initiating canagliflozin between April 2013 and December 2016. The samples were randomly and equally split into training and testing sets. We identified 41 predictor candidates using information from the year prior to canagliflozin initiation, and applied four machine learning approaches (elastic net, least absolute shrinkage and selection operator [LASSO], gradient boosting machine and random forests) to predict LEA risk after canagliflozin initiation.Results: The incidence rate of LEA was 0.57% over a median 1.5 years follow‐up. LASSO produced the best prediction, yielding a C‐statistic of 0.81 (95% CI: 0.76, 0.86). Among individuals categorized in the top 5% of the risk score, the actual incidence rate of LEA was 3.74%. Among the 16 factors selected by LASSO, history of LEA [adjusted odds ratio (aOR): 33.6 (13.8, 81.9)] and loop diuretic use [aOR: 3.6 (1.8,7.3)] had the strongest associations with LEA incidence.Conclusions: Our machine learning model efficiently predicted the risk of LEA among diabetes patients undergoing canagliflozin treatment. The risk score may support optimized treatment decisions and thus improve health outcomes of diabetes patients.Keywords
This publication has 44 references indexed in Scilit:
- Machine Learning in MedicineCirculation, 2015
- Why the C-statistic is not informative to evaluate early warning scores and what metrics to useCritical Care, 2015
- Gender Differences of Lower Extremity Amputation Risk in Patients With Diabetic FootThe International Journal of Lower Extremity Wounds, 2014
- Incidence and risk factors of lower extremity amputations in people with type 2 diabetes in Taiwan, 2001–2010 2001–2010年台湾糖尿病患者的下肢截肢发生率及其相关危险因素的研究Journal of Diabetes, 2014
- Construction of confidence regions in the ROC space after the estimation of the optimal Youden index‐based cut‐off pointBiometrics, 2013
- Impact of diabetes on costs before and after major lower extremity amputations in GermanyJournal of Diabetes and its Complications, 2013
- Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trialAmerican Heart Journal, 2013
- The Diabetic Foot: Quality of LifeClinical Infectious Diseases, 2004
- The Use of Automated Data to Identify Complications and Comorbidities of DiabetesJournal of Clinical Epidemiology, 1999
- Long-Term Complications of Diabetes MellitusNew England Journal of Medicine, 1993